Search Results - R. V. Zelchan
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY by V. I. Chernov, T. L. Kravchuk, R. V. Zelchan, D. M. Podoplekin, V. E. Goldberg
Published 2016-02-01
Article -
2
RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES by V. I. Chernov, O. D. Bragina, I. G. Sinilkin, A. A. Titskaya, R. V. Zelchan
Published 2016-07-01
Article -
3
THE PRESENCE OF VARIOUS POPULATIONS OF CIRCULATING TUMOR CELLS IN THE BLOOD OF BREAST CANCER PATIENTS BEFORE TREATMENT: ASSOCIATION WITH FIVE-YEAR METASTASIS-FREE SURVIVAL by E. V. Kaigorodova, N. A. Tarabanovskaya, P. V. Surkova, R. V. Zelchan, E. Yu. Garbukov
Published 2020-12-01
Article -
4
Radionuclide teranostic of malignancies by V. I. Chernov, O. D. Bragina, I. G. Sinilkin, A. A. Medvedeva, R. V. Zel’chan
Published 2016-11-01
Article -
5
-
6
-
7
Nuclear medicine as a tool for diagnosis and targeted cancer therapy by V. I. Chernov, A. A. Medvedeva, I. G. Sinilkin, R. V. Zelchan, O. D. Bragina, E. L. Choynzonov
Published 2018-03-01
Article -
8
Comparative Analysis of the Clinical Use of 99mTechnetium-Labeled Recombinant Target Molecules in Different Dosages for the Radionuclide Diagnosis of Her2-Positive Breast Cancer by O. D. Bragina, V. I. Chernov, E. Yu. Garbukov, R. V. Zelchan, A. A. Medvedeva, V. M. Tolmachev
Published 2021-06-01
Article -
9
Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29 by O. D. Bragina, V. I. Chernov, A. A. Medvedeva, R. V. Zelchan, M. S. Larkina, S. M. Deyev, V. M. Tolmachev
Published 2020-08-01
Article -
10
Study of the diagnostic efficiency of single-photon emission computed tomography with [<sup>99m</sup>Tc]Tc-1-THIO-D-glucose in visualization of brain tumors by R. V. Zelchan, A. A. Medvedeva, O. D. Bragina, A. N. Rybina, A. I. Ryabova, V. I. Chernov, E. L. Choinzonov
Published 2022-11-01
Article -
11
-
12
-
13
-
14
EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT) by O. D. Bragina, V. I. Chernov, R. V. Zelchan, A. A. Medvedeva, I. G. Frolova, E. A. Dudnikova, V. E. Goldberg, V. M. Tolmachev
Published 2021-10-01
Article -
15
Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties by M. S. Larkina, A. S. Semenov, R. V. Zelchan, E. V. Podrezova, O. D. Bragina, M. S. Yusubov, V. S. Skuridin, V. I. Chernov, M. V. Belousov, M. S. Timofeev
Published 2018-03-01
Article -
16
-
17
Clinical Testing of a New Radiopharmaceutical [<sup>99m</sup>Тс]-Al<sub>2</sub>O<sub>3</sub> for the Diagnosis of Sentinel Lymph Nodes by А. A. Medvedeva, V. I. Chernov, R. V. Zelchan, O. D. Bragina, A. A. Rybina, V. S. Skuridin, E. S. Stasyuk, S. Yu. Chizhevskaya, A. V. Goldberg, E. Yu. Garbukov
Published 2022-11-01
Article -
18
The role of <sup>18</sup>F-FDG PET/CT in evaluation of therapy effectiveness and prognosis of lymphomas by N. G. Chanchikova, V. I. Chernov, E. A. Dudnikova, E. A. Karlova, A. S. Savelyeva, O. A. Silkina, R. V. Zelchan, O. D. Bragin, A. A. Medvedeva, E. V. Berezneeva
Published 2021-07-01
Article -
19
THE FIRST EXPERIENCE OF USING 99MTC-1-THIO-D-GLUCOSE FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGING OF LYMPHOMAS by V. I. Chernov, E. A. Dudnikova, R. V. Zelchan, T. L. Kravchuk, A. V. Danilova, A. A. Medvedeva, I. G. Sinilkin, O. D. Bragina, V. E. Goldberg, A. V. Goldberg, I. G. Frolova
Published 2018-09-01
Article -
20
RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS by V. I. Chernov, T. L. Kravchuk, R. V. Zel’chan, V. E. Gol’dberg, N. O. Popova, E. I. Simolina, V. V. Vysockaja, Ju. V. Belevich, I. G. Sinilkin, A. А. Medvedeva, O. D. Bragina
Published 2016-12-01
Article